英文名稱 | Sophoraflavanone G |
---|---|
中文名稱 | 苦參新醇F/苦參醇F/槐黃烷酮G/槐屬二氫黃酮G/苦參新醇/降苦參酮 |
CAS號 | 97938-30-2 |
分子式 | C25H28O6 |
分子量 | 424.49 |
熔點 | 178-180 °C |
沸點 | 659.3±55.0 °C | Condition: Press: 760 Torr |
酸度系數(shù)pKa | 7.66±0.40 | Condition: Most Acidic Temp: 25 °C |
英文名稱 | Sophoraflavanone G |
---|---|
中文名稱 | 苦參新醇F/苦參醇F/槐黃烷酮G/槐屬二氫黃酮G/苦參新醇/降苦參酮 |
CAS號 | 97938-30-2 |
分子式 | C25H28O6 |
分子量 | 424.49 |
熔點 | 178-180 °C |
沸點 | 659.3±55.0 °C | Condition: Press: 760 Torr |
酸度系數(shù)pKa | 7.66±0.40 | Condition: Most Acidic Temp: 25 °C |
WKQ-0643354
中文名稱:苦參新醇F
中文別名:苦參醇F;槐黃烷酮G;槐屬二氫黃酮G;苦參新醇;降苦參酮
英文名稱:Sophoraflavanone G
英文別名:4H-1-Benzopyran-4-one, 2-(2,4-dihydroxyphenyl)-2,3-dihydro-5,7-dihydroxy-8-[(2R)-5-methyl-2-(1-methylethenyl)-4-hexenyl]-, (2S)- (9CI);4H-1-Benzopyran-4-one, 2-(2,4-dihydroxyphenyl)-2,3-dihydro-5,7-dihydroxy-8-[5-methyl-2-(1-methylethenyl)-4-hexenyl]-, [S-(R*,S*)]-;(2S)-2-(2,4-Dihydroxyphenyl)-2,3-dihydro-5,7-dihydroxy-8-[(2R)-5-methyl-2-(1-methylethenyl)-4-hexen-1-yl]-4H-1-benzopyran-4-one;(-)-Vexibinol;Kushenol F;Kushnol F;Norkurarinone;Sophoraflavanone G;Vexibinol;
分子式:C25H28O6
分子量:424.49
CAS號:97938-30-2
純度:HPLC≥98%
熔點:178-180 °C
沸點:659.3±55.0 °C | Condition: Press: 760 Torr
密度:1.266±0.06 g/cm3 | Condition: Temp: 20 °C Press: 760 Torr
酸系度數(shù):7.66±0.40 | Condition: Most Acidic Temp: 25 °C
儲存條件:-20℃,干燥、避光、密封
規(guī)格:5mg10mg20mg50mg100mg500mg1g2g等應(yīng)客戶需求包裝
供應(yīng)單位:四川省維克奇生物科技有限公司
供應(yīng)電話:028-81700200/4008005713
四川省維克奇生物科技有限公司生產(chǎn)中藥類標(biāo)準(zhǔn)品和天然植物有效單體,主打中藥對照品/標(biāo)準(zhǔn)品/天然植物有效單體,化學(xué)合成,抗生素三大板塊。公司推出丹參系列、龍膽系列、蟲草系列等,敬請關(guān)注! 新批次有現(xiàn)貨,歡迎咨詢。
Integrated metabolomics and network pharmacology strategy for ascertaining the quality marker of flavonoids for Sophora flavescens | ||
來源:SCI:JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS | 作者:Lei Chen | 備注:影響因子:3.209 |
引用描述 | ||
Reference standards were used in this study, twenty-eight of them were self-made by our laboratory in the early stage [[16], [17], [18]], including 3′-hydroxy-daidzein, calycosin, trifolirhizin, genistein, maackiain, sophoraflavescenol, noranhydroicaritin, shandougenines B, kushenol C, leachianone G, liquiritigenin, 8-(3-hydroxymethyl-2-butenyl)-5,7,2′,4′-tetrahydroxyflavanone, 2′-hydroxy-isoxanthohumol, (2R)-3β,7,4′-trihydroxy-5-methoxy-8-prenylflavanone, (2R)-3α,7,4′-trihydroxy-5-methoxy-8-prenylflavanone, 4H-1-benzopyran-4-one,2-(4-hydroxyphenyl)-3,7-dihydroxy-5-methoxy-8-[5-methyl-2-(1-methylethenyl)-4-hexenyl], isoxanthohumol, kurarinol, kushenol N, kurarinone, isokurarinone, kushenol U, 2′-methoxykurarinone, norkurarinone, kushenol A, kushenol L, kuraridin, xanthohumol and biochanin A, kushenol B and kushenol M were purchased from Sichuan Weikeqi Biological Technology Co., Ltd (Sichuan China) and Wuhan Tianzhi Biotechnology Co., Ltd. (Wuhan, China), kushenol E and kushenol X were donated by Dr. YY Jiang from Beijing University of Chinese Medicine. The purity of the above standards is greater than 98 %. |